Genetic Variability of Histone Deacetylase 9 (HDAC9) and Treatment Response of Patients with locally advanced Rectal Cancer: Biomarkers for Therapeutic Sensibilities and Implications for Intensification of neoadjuvant Chemoradiotherapy

Schirmer M. A.; Hubert L.; Leu M.; Hess C. F.

首页> 外文期刊>Strahlentherapie und Onkologie >Genetic Variability of Histone Deacetylase 9 (HDAC9) and Treatment Response of Patients with locally advanced Rectal Cancer: Biomarkers for Therapeutic Sensibilities and Implications for Intensification of neoadjuvant Chemoradiotherapy

【24h】

Genetic Variability of Histone Deacetylase 9 (HDAC9) and Treatment Response of Patients with locally advanced Rectal Cancer: Biomarkers for Therapeutic Sensibilities and Implications for Intensification of neoadjuvant Chemoradiotherapy

机译：局部晚期癌症患者的组蛋白脱乙酰酶9（HDAC9）和治疗响应的遗传变异：生物标志物，用于治疗敏感性和对新辅助化学疗法的强化的影响

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Strahlentherapie und Onkologie》 |2019年第1期|共1页
作者
Schirmer M. A.; Hubert L.; Leu M.; Hess C. F.;
展开▼
作者单位

Univ Med Gottingen Klin Strahlentherapie &

Radioonkol Gottingen Germany;

Univ Med Gottingen Klin Strahlentherapie &

Radioonkol Gottingen Germany;

Univ Med Gottingen Klin Strahlentherapie &

Radioonkol Gottingen Germany;

Univ Med Gottingen Klin Strahlentherapie &

Radioonkol Gottingen Germany;

展开▼
收录信息
原文格式 PDF
正文语种 ger
中图分类放射医学;
关键词

相似文献

外文文献
中文文献
专利

1. Genetic Variability of Histone Deacetylase 9 (HDAC9) and Treatment Response of Patients with locally advanced Rectal Cancer: Biomarkers for Therapeutic Sensibilities and Implications for Intensification of neoadjuvant Chemoradiotherapy [J] . Schirmer M. A., Hubert L., Leu M., Strahlentherapie und Onkologie . 2019,第Suppla1期

机译：局部晚期癌症患者的组蛋白脱乙酰酶9（HDAC9）和治疗响应的遗传变异：生物标志物，用于治疗敏感性和对新辅助化学疗法的强化的影响
2. Intensified concurrent chemoradiotherapy with 5-fluorouracil and irinotecan as neoadjuvant treatment in patients with locally advanced rectal cancer [J] . G Klautke, P Feyerherd, K Ludwig, British Journal of Cancer . 2005,第7期

机译：5-氟尿嘧啶和伊立替康强化同时放化疗作为局部晚期直肠癌患者的新辅助治疗
3. Worse treatment response to neoadjuvant chemoradiotherapy in young patients with locally advanced rectal cancer [J] . Yiyi Zhang, Liangliang Yan, Yong Wu, BMC Cancer . 2020,第1期

机译：对局部晚期癌症患者的新辅助化学疗法更糟糕的治疗反应
4. Neoadjuvant treatment in rectal cancer: do we always need radiotherapy-or can we risk assess locally advanced rectal cancer better? [C] . Rob Glynne-Jones St. Gallen EORTC Gastrointestinal Cancer Conference . 2012

机译：Neoadjuvant在直肠癌中治疗：我们总是需要放射治疗 - 或者我们是否可以更好地评估当地先进的直肠癌？
5. Intenzivnej?e neoadjuvantno zdravljenje lokalno napredovalnega raka danke =Intensified neoadjuvant treatment of locally advanced rectal cancer [D] . Golo, Danijela. 2018

机译：强烈的Neoadjuvant治疗局部晚期癌症射线=加强Neoadjuvant治疗局部晚期直肠癌
6. CT texture analysis in patients with locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy: A potential imaging biomarker for treatment response and prognosis [O] . Choong Guen Chee, Young Hoon Kim, Kyoung Ho Lee, -1

机译：新辅助放化疗治疗局部晚期直肠癌患者的CT纹理分析：治疗反应和预后的潜在影像生物标志物
7. CT texture analysis in patients with locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy: A potential imaging biomarker for treatment response and prognosis. [O] . Choong Guen Chee, Young Hoon Kim, Kyoung Ho Lee, 2017

机译：新辅助化放疗治疗局部晚期直肠癌患者的CT纹理分析：治疗反应和预后的潜在影像生物标志物。

Genetic Variability of Histone Deacetylase 9 (HDAC9) and Treatment Response of Patients with locally advanced Rectal Cancer: Biomarkers for Therapeutic Sensibilities and Implications for Intensification of neoadjuvant Chemoradiotherapy

著录项

相似文献

相关主题

期刊订阅